摘要
以4-[3-(哌嗪-1-羰基)苄基]-2H-酞嗪-1-酮为原料,经与2-氟-5-[(4-氧代-3,4-二氢酞嗪-1-基)甲基]苯甲酸缩合,得到有关物质A;以4-[3-(哌嗪-1-羰基)苄基]-2H-酞嗪-1-酮为原料,经与丁酸缩合,得到有关物质B;以苯酞、3-氰基苯甲醛为原料,经亲核取代、氰基水解、肼解、酰胺化反应,得到有关物质C.这3种有关物质的制备方法和反应条件温和,操作简单,纯度高,其化学结构均经LR-EI-MS,^1H-NMR和^(13)C-NMR确证,可以用于奥拉帕利的质量研究和控制.
Related substance A was obtained by condensation of 4-[3-(piperazin-1-carbonyl)benzyl-2H-phthalazin-1-one with 2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyllbenzoic acid;related substance B was obtained by condensation of 4-[3-(piperazin-1-carbonyl)benzyll-2H-phthalazin-1-one with butyric acid;related substance C was obtained from phthalide and 3-cyanobenzaldehyde via nucleophilic substitution,cyanohydrolysis,hydrazinolysis and amidation.These related substances were prepared under mild reaction conditions,simple operation and high purity,and their chemical structures were confirmed by LR-EI-MS,^(1)H-NMR and ^(13)C-NMR,which can be used for the quality study and control of olaparib.
作者
李宏名
胡瑞馨
郑维江
张娇
LI Hongming;HU Ruixin;ZHENG wejang;ZHANG Jiao(College of Continuing Education,Wuhan Polytechnic University,Wuhan 611130,China;Sinopharm Chuankang Pharmaceutical Co.,Ltd,Chengdu 611731,China;College of Horticulture,Sichuan Agricultural University,Chengdu 611130,China;Sichuan Kelun Pharmaceutical Research Institute Co.,Ltd,Chengdu 611138,China)
出处
《牡丹江师范学院学报(自然科学版)》
2024年第1期26-30,共5页
Journal of Mudanjiang Normal University:Natural Sciences Edition
基金
国家“重大新药创制”科技重大专项资助项目(2012ZX092021-013)
成都市高新区重点科技创新计划资助项目(15DFZD023)。
关键词
奥拉帕利
有关物质
合成
结构确证
olaprib
related substances
synthesis
structural characterization